With a market capitalization (market cap) of $6.11B — a measure of how much the company is worth — Hims & Hers Health, Inc. is the 1274th most valuable company in Healthcare as of August 18, 2026. Shares trade at $27.39, down +4.26% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Visit websiteAs of August 18, 2026, Hims & Hers Health, Inc. (HIMS) is worth $6.11B — this is its market capitalization, the total value of all its outstanding shares.
Hims & Hers Health, Inc.’s market cap is $6.11B, which ranks it #1274 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Hims & Hers Health, Inc. (HIMS) shares trade at $27.39, down 4.26% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025
Hims & Hers Health, Inc. trades at a price-to-earnings (P/E) ratio of 48.1, based on its latest share price and annual earnings per share.